Bromodomain Extraterminal (BET) Family Inhibitor JQ1 Inhibits Nuclear Maturation and Cytoplasmic Organization of Oocytes.

被引:0
|
作者
Poojary, Keerthana Karunakar [1 ]
Kumari, Sandhya [1 ]
Adiga, Satish K. [1 ]
Kalthur, Guruprasad [1 ]
机构
[1] Kasturba Med Coll & Hosp, Udupi, India
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
O-051
引用
收藏
页码:68A / 68A
页数:1
相关论文
共 50 条
  • [1] Bromodomain and extraterminal protein inhibitor JQ1 induces maturation arrest and disrupts the cytoplasmic organization in mouse oocytes under in vitro conditions
    Keerthana Karunakar Poojary
    Jyolsna Ponnaratta Kunhiraman
    Vanishree Vasave Madhvacharya
    Sandhya Kumari
    Navami Krishna
    Suresh P S
    Rajanikant G K
    Srinivas Mutalik
    Nadeem Khan Ghani
    Shama Prasada Kabekkodu
    Thottethodi Subrahmanya Keshava Prasad
    Satish Kumar Adiga
    Guruprasad Kalthur
    Scientific Reports, 15 (1)
  • [2] Scalable syntheses of the BET bromodomain inhibitor JQ1
    Syeda, Shameem Sultana
    Jakkaraj, Sudhakar
    Georg, Gunda I.
    TETRAHEDRON LETTERS, 2015, 56 (23) : 3454 - 3457
  • [3] THE BET BROMODOMAIN INHIBITOR JQ1 DIMINISHED RENAL FIBROSIS
    Rayego-Mateos, Sandra
    Luis Morgado-Pascual, Jose
    Suarez-Alvarez Suarez-Alvarez, Beatriz
    Orejudo, Macarena
    Rodrigues-Diez, Raul R.
    Marquez-Exposito, Laura
    Egido, Jesus
    Ortiz, Alberto
    Lopez-Larrea, Carlos
    Ruiz-Ortega, Marta
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 102 - 102
  • [4] Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model
    Zhu, Xuguang
    Enomoto, Keisuke
    Zhao, Li
    Zhu, Yuelin J.
    Willingham, Mark C.
    Meltzer, Paul
    Qi, Jun
    Cheng, Sheue-yann
    CLINICAL CANCER RESEARCH, 2017, 23 (02) : 430 - 440
  • [5] Inhibiting STAT5 by the BET Bromodomain Inhibitor JQ1 Disrupts Human Dendritic Cell Maturation
    Toniolo, Patricia A.
    Liu, Suhu
    Yeh, Jennifer E.
    Moraes-Vieira, Pedro M.
    Walker, Sarah R.
    Vafaizadeh, Vida
    Barbuto, Jose Alexandre M.
    Frank, David A.
    JOURNAL OF IMMUNOLOGY, 2015, 194 (07): : 3180 - 3190
  • [6] BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells
    Mio, Catia
    Conzatti, Ketty
    Baldan, Federica
    Allegri, Lorenzo
    Sponziello, Marialuisa
    Rosignolo, Francesca
    Russo, Diego
    Filetti, Sebastiano
    Damante, Giusepe
    ONCOLOGY REPORTS, 2018, 39 (02) : 582 - 588
  • [7] The BET-bromodomain inhibitor JQ1 mitigates vemurafenib drug resistance in melanoma
    Zhao, Bei
    Cheng, Xiankui
    Zhou, Xiyuan
    MELANOMA RESEARCH, 2018, 28 (06) : 521 - 526
  • [8] The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma
    Bid, Hemant K.
    Phelps, Doris A.
    Xaio, Linlin
    Guttridge, Denis C.
    Lin, Jiayuh
    London, Cheryl
    Baker, Laurence H.
    Mo, Xiaokui
    Houghton, Peter J.
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (05) : 1018 - 1028
  • [9] Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins by JQ1 Unravels a Novel Epigenetic Modulation to Control Lipid Homeostasis
    Tonini, Claudia
    Colardo, Mayra
    Colella, Barbara
    Di Bartolomeo, Sabrina
    Berardinelli, Francesco
    Caretti, Giuseppina
    Pallottini, Valentina
    Segatto, Marco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (04)
  • [10] The Bet Bromodomain Inhibitor, (+)-JQ1, Inhibits Neointima Formation Following Acute Vascular Injury Via Pten Upregulation
    Strand, Keith
    Lu, Sizhao
    Mutryn, Marie
    Dubner, Allison
    Jolly, Austin
    Nemenoff, Raphael
    Cavasin, Maria A.
    McKinsey, Timothy A.
    Evans, Mary C. Weiser
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41